Table 1.

Serum MCP-1 and MIP-1α levels in patients treated with anti-TNF therapy vs controls.

Controls, n = 13Day 0RA, n = 8 Day 1Day 60Day 0AS, n = 6 Day 1Day 60
MCP-1, pg/ml85.9 ± 42.477.6 ± 37.159.3 ± 20.570.2 ± 27.8118.6 ± 57.385.1 ± 43.2127.4 ± 33.6
MIP-1α, pg/ml8.1 ± 2.445.4 ± 61.4**19.4 ± 24.19.3 ± 3.881.8 ± 104.6*44.3 ± 59.732.7 ± 34.1
  • * p < 0.01,

  • ** p < 0.05 compared to controls.

  • p < 0.05 compared to Day 0. RA: rheumatoid arthritis; AS: ankylosing spondylitis; MCP: monocyte chemoattractant protein; MIP: macropage inflammatory protein.